# Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases

> **NCT02510378** · PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 47 (estimated)

## Conditions studied

- Stage IV Rectal Cancer, Liver Metastasis, Resectable

## Interventions

- **RADIATION:** Short course radiotherapy

## Key facts

- **NCT ID:** NCT02510378
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2020-12
- **Final completion:** 2022-12
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510378, "Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02510378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*